Leal Health (fka TrialJectory)
Acquired
Treatments. Choices. Hope.
- Headquarters
- Closter, New Jersey
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B2C
- Website
- trialjectory.com
- Total Funding
- $27.0M
- Last Round
- $4.2M Series BDec 2023
About
Leal Health (formerly TrialJectory) is a patient-first AI platform dedicated to democratizing access to advanced cancer treatment. Its AI-powered decision-support platform matches patients to clinical trials and cutting-edge cancer treatments based on self-reported clinical information, providing a personalized list of options in minutes. The platform serves patients, oncologists, and biopharma companies, and has facilitated over 5 million treatment matches. Recognized by TIME as one of the Best Inventions of 2020, Leal partners with leading cancer advocacy organizations to ensure unbiased access. In February 2026, Leal Health was acquired by Nexus Precision Health.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account